Navigation Links
EXAMINE-Studie zur kardiovaskulären Sicherheit von Alogliptin erreicht primären Endpunkt: keine Erhöhung des kardiovaskulären Risikos bei Risikopatienten mit Typ-2 Diabetes
Date:9/11/2013

rapie versus der Placebobehandlung zusätzlich zur Standardtherapie bei Patienten mit Diabetes Typ 2 und einem erst kurz vorher aufgetretenen akuten Koronarsyndrom (innerhalb von 15 bis 90 Tagen vor der Randomisierung). Die Studie hatte als primären kombinierten Endpunkt kardiovaskulären Tod, nicht tödlichen Herzinfarkt und nicht tödlichen Schlaganfall.

In der Alogliptin-Gruppe erhielten 71,4 % der Patienten 25 mg, 25,7 % 12,5 mg und 2,9 % 6,25 mg täglich. Die Alogliptin-Dosierungen wurden entsprechend der Nierenfunktion angepasst: geschätzte glomeruläre Filtrationsrate (gGFR) durch die MDRD-Formel (Modification in Diet in Renal Disease) > 60 ml/min, 25 mg täglich; < 60 ml/min und  > 30 ml/min, 12,5 mg täglich; und < 30 ml/min, 6,25 mg täglich. Das Studienpräparat wurde in beiden Gruppen ähnlich häufig vorzeitig abgesetzt. (20,9 % bzw. 22,6 % der Patienten). Die mittlere Expositionsdauer betrug 533 Tage (Quartilsabstand 280 bis 751 Tage). Zum Ende der Studie betrug die mittlere Veränderung des HbA1c versus dem Ausgangspunkt 0,33% bzw. 0,03% in der Alogliptin- und der Placebogruppe, und der Mittelwert der Differenz der HbA1c-Werte zwischen Alogliptin und Placebo betrug -0,36% (95 % KI, -0,43, -0.28, p<0,001). Die Ergebnisse der einzelnen Komponenten des primären Endpunktes stimmten mit dessen Gesamtauswertung überein. Dies traf auch für die Gesamtmortalität und den kardiovaskulären Tod zu. Die Unterschiede waren jeweils nicht signifikant.

Takeda führte die globale EXAMINE-Studie gemäß den Leitlinien der US-amerikanischen Food and Drug Administration (FDA) von 2008 („Guidance for Industry: Diabetes Mellitus – Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes) durch. Die EXAMINE-Ergebnisse werden nach Abschluss aller Analysen ordnung
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. American College of Chest Physicians (ACCP) und Simbionix arbeiten zusammen, um klinische Ausbildung und Patientensicherheit zu verbessern
2. Messe/Konferenz InnoPack Pharma legt den Fokus auf innovative Verpackungen für Compliance und Sicherheit
3. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
4. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
5. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood Glucose Monitoring Systems
8. Clinilabs Sponsors The ADAs 2013 Step Out: Walk to Stop Diabetes
9. GSMA mHealth Grand Tour Highlights How Mobile Technology Could Help Prevent 5 Million People In The EU From Developing Diabetes
10. Elcelyx Therapeutics NewMet for Type 2 Diabetes Meets Primary Endpoint in Phase 2b Study
11. Bio-Solutions Corp. Expanding in Booming Diabetes Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... According to a new market research report "Blood ... Application (Aerobic, Anaerobic, Yeast/ Fungi) & End User (Hospital, Reference ... published by MarketsandMarkets, The global Blood Culture Tests Market is ... in 2014 at a CAGR of 7.2% from 2014-2019. ... ma rket data T ables and ...
(Date:7/7/2015)... , June 30, 2015 ... announced the addition of the "The New ... report to their offering. The report, ... Market, provides unique insights into the current development ... global preclinical development outsourcing market. The report is ...
(Date:7/7/2015)... July 7, 2015 ... P&R annonce l,acquisition de 20% du Groupe ... mondial, spécialisée dans la fabrication de médicaments ... hyaluronique.      (Logo: http://photos.prnewswire.com/prnh/20150707/232398LOGO) , ... principaux groupes chimiques et pharmaceutiques italiens, qui ...
Breaking Medicine Technology:Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 2New Trends in the 2015 Global Preclinical Development Outsourcing Market 3New Trends in the 2015 Global Preclinical Development Outsourcing Market 4New Trends in the 2015 Global Preclinical Development Outsourcing Market 5
... Laboratory (IL) today announced total worldwide sales in 2010 ... 11.5% growth v. previous year in current, and 10.3% ... segments, Critical Care and Hemostasis Diagnostics, worldwide growth in ... 9.7% (8.9% in local currencies), respectively.   ...
... 22, 2011 Later this month, Quest Diagnostics ... benefit from $39 billion in federal incentives by ... EHR Road Test tour was developed to help hospitals ... and financial benefits of electronic health records and Care360 EHR. ...
Cached Medicine Technology:Instrumentation Laboratory Achieves Record Sales in 2010 2Instrumentation Laboratory Achieves Record Sales in 2010 3Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR 2Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR 3
(Date:7/7/2015)... NY (PRWEB) , ... July 07, 2015 , ... Difass ... that can help pass those long, stressful days at work is knowing that there ... always as laid back and stress free as imagined. Planning for a vacation can ...
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers ... Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for ... who have sex with men (MSM) and transgender women, the groups at highest ...
(Date:7/7/2015)... ... ... SC&H Group, a leading audit, tax, and consulting firm, recently hosted its ... company-wide volunteering efforts. , On an annual basis, in coordination with Business Volunteers ... throughout Baltimore and Washington D.C. , This year, SC&H Group’s team in ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... further enhance the experience for its patient community using its IDF ePHR, an ... patients with primary immunodeficiency diseases (PI) to easily track their health information, including ...
(Date:7/7/2015)... New York, NY (PRWEB) , ... July 07, 2015 , ... ... , a new convenient online destination for HSA holders. HSAstore.com makes it simple to ... List to help consumers better understand their accounts. , According to a ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... tendon in the eye socket may help stop a migraine ... socket just before an attack starts.// The pain is due ... a condition known as trochleitis. A new study suggests that ... migraine itself. ,According to researchers in Texas, they ...
... appear to cut the risk of a heart attack ... bypass surgery, allows doctors to open clogged coronary arteries ... the narrowest point and inflating the balloon. But 3 ... will suffer a major setback within 4 years. Some ...
... defibrillators in people who have had heart attacks prevented sudden ... findings will likely lead to a dramatic and costly shift ... by adding a $20,000 defibrillator to the medicines now in ... the preventive use of these devices in people without apparent ...
... but it also prevents many other cancers through activating vitamin ... causes sunburn// - as a risk factor for melanoma, and ... not generally realised is that the reverse may also be ... Grant, an independent researcher based in Hopkins University has analysed ...
... antimicrobial properties of honey could prove effective in arresting ... dental caries, a New Zealand researcher will report at ... month. ,An enzyme in honey that produces hydrogen ... honey, according to Dr. Peter C. Molan, associate professor ...
... by taking a history of symptoms, a physical exam, ... rule out other causes, such as kidney disease.// Even ... blood test allows doctors to accurately find out whether ... congestive heart failure. ,This test is the most ...
Cached Medicine News:
A single tube that performs two rapid tests for E. coli from culture. ColiScreen™ combines both the indole test with the glucuronidase test to increase the specificity....
Legionella provides rapid, accurate results that aid in the presumptive diagnosis of Legionella infection (Legionnaires' Disease)....
... The Trinity Biotech Captia™ ... Assay (ELISA) is intended for ... antibodies (IgG and IgM) to ... in serum from patients with ...
The GoodKnight® 425 Bi-Level® device is suitable for travel and includes features such as automatic altitude compensation, optional cigarette lighter adapter and portable battery pack...
Medicine Products: